Rhumbline Advisers Moderna, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Moderna, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 545,905 shares of MRNA stock, worth $21.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

545,905

Previous 585,992 6.84%

Holding current value

$21.6 Million

Previous $69.6 Million 47.57%

% of portfolio

0.03%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$63.64 - $125.14 $2.55 Million - $5.02 Million	-40,087 Reduced 6.84%	545,905 $36.5 Million
Q2 2024 Aug 01, 2024	SELL	$101.21 - $166.61 $293,509 - $483,169	-2,900 Reduced 0.49%	585,992 $69.6 Million
Q1 2024 May 09, 2024	BUY	$85.37 - $115.44 $406,446 - $549,609	4,761 Added 0.82%	588,892 $62.8 Million
Q4 2023 Feb 08, 2024	SELL	$69.51 - $104.43 $228,062 - $342,634	-3,281 Reduced 0.56%	584,131 $58.1 Million
Q3 2023 Nov 09, 2023	BUY	$96.41 - $126.61 $590,704 - $775,739	6,127 Added 1.05%	587,412 $60.7 Million
Q2 2023 Aug 08, 2023	BUY	$118.5 - $160.53 $14,694 - $19,905	124 Added 0.02%	581,285 $70.6 Million
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $1 Million - $1.46 Million	-7,394 Reduced 1.26%	581,161 $89.3 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $1.47 Million - $2.61 Million	12,421 Added 2.16%	588,555 $106 Million
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $670,047 - $1.1 Million	5,675 Added 0.99%	576,134 $68.1 Million
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $1.95 Million - $2.93 Million	16,608 Added 3.0%	570,459 $81.5 Million
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $3.28 Million - $6.1 Million	25,931 Added 4.91%	553,851 $95.4 Million
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $3.86 Million - $6.29 Million	17,074 Added 3.34%	527,920 $134 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $36.5 Million - $79.7 Million	164,555 Added 47.52%	510,846 $197 Million
Q2 2021 Aug 05, 2021	BUY	$129.91 - $234.98 $3.47 Million - $6.28 Million	26,740 Added 8.37%	346,291 $81.4 Million
Q1 2021 May 06, 2021	BUY	$109.18 - $185.98 $192,811 - $328,440	1,766 Added 0.56%	319,551 $41.8 Million
Q4 2020 Feb 10, 2021	SELL	$65.74 - $169.86 $249,483 - $644,618	-3,795 Reduced 1.18%	317,785 $33.2 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $174,159 - $303,994	3,205 Added 1.01%	321,580 $22.8 Million
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $2.56 Million - $6.91 Million	86,381 Added 37.23%	318,375 $20.4 Million
Q1 2020 May 06, 2020	BUY	$17.78 - $31.58 $728,251 - $1.29 Million	40,959 Added 21.44%	231,994 $6.95 Million
Q4 2019 Feb 05, 2020	BUY	$13.93 - $21.28 $290,259 - $443,411	20,837 Added 12.24%	191,035 $3.74 Million
Q3 2019 Oct 23, 2019	BUY	$12.26 - $18.07 $1.69 Million - $2.49 Million	137,924 Added 427.35%	170,198 $2.71 Million
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $225,981 - $467,468	16,495 Added 104.54%	32,274 $472,000
Q1 2019 May 01, 2019	BUY	$14.45 - $23.7 $228,006 - $373,962	15,779 New	15,779 $321,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Moderna, Inc. Transaction History